Green Alpha Advisors, LLC Moderna, Inc. Transaction History

Green Alpha Advisors, LLC

$112 Million
Q4 2024

A detailed history of Green Alpha Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 16,900 shares of MRNA stock, worth $511,563. This represents 0.63% of its overall portfolio holdings.

Number of Shares

16,900

Previous 10,913 54.86%

Holding current value

$511,563

Previous $729,000 3.7%

% of portfolio

0.63%

Previous 0.59%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$36.85 - $63.93 $220,620 - $382,748	5,987 Added 54.86%	16,900 $702,000
Q3 2024 Oct 07, 2024	BUY	$63.64 - $125.14 $40,538 - $79,714	637 Added 6.2%	10,913 $729,000
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $270,837 - $445,848	-2,676 Reduced 20.66%	10,276 $1.22 Million
Q1 2024 Apr 09, 2024	BUY	$85.37 - $115.44 $115,590 - $156,305	1,354 Added 11.67%	12,952 $1.38 Million
Q4 2023 Jan 04, 2024	SELL	$69.51 - $104.43 $9,244 - $13,889	-133 Reduced 1.13%	11,598 $1.15 Million
Q3 2023 Oct 10, 2023	BUY	$96.41 - $126.61 $59,967 - $78,751	622 Added 5.6%	11,731 $1.21 Million
Q2 2023 Jul 06, 2023	BUY	$118.5 - $160.53 $155,353 - $210,454	1,311 Added 13.38%	11,109 $1.35 Million
Q1 2023 Apr 06, 2023	SELL	$135.66 - $197.02 $100,524 - $145,991	-741 Reduced 7.03%	9,798 $1.5 Million
Q4 2022 Jan 12, 2023	BUY	$118.38 - $210.04 $189,881 - $336,904	1,604 Added 17.95%	10,539 $0
Q3 2022 Oct 14, 2022	SELL	$118.07 - $194.18 $9.17 Million - $15.1 Million	-77,650 Reduced 89.68%	8,935 $1.06 Million
Q2 2022 Jul 08, 2022	BUY	$117.13 - $176.59 $9.23 Million - $13.9 Million	78,801 Added 1012.35%	86,585 $12.4 Million
Q1 2022 Apr 19, 2022	BUY	$126.46 - $235.05 $91,177 - $169,471	721 Added 10.21%	7,784 $1.34 Million
Q4 2021 Jan 12, 2022	BUY	$225.82 - $368.51 $73,617 - $120,134	326 Added 4.84%	7,063 $1.79 Million
Q3 2021 Oct 12, 2021	SELL	$221.9 - $484.47 $196,381 - $428,755	-885 Reduced 11.61%	6,737 $2.59 Million
Q2 2021 Jul 22, 2021	SELL	$129.91 - $234.98 $649,290 - $1.17 Million	-4,998 Reduced 39.6%	7,622 $1.79 Million
Q1 2021 Jul 22, 2021	SELL	$109.18 - $185.98 $212,245 - $361,545	-1,944 Reduced 13.35%	12,620 $1.65 Million
Q4 2020 Jul 22, 2021	BUY	$65.74 - $169.86 $957,437 - $2.47 Million	14,564 New	14,564 $1.52 Million

Others Institutions Holding MRNA

# of Institutions

925

Shares Held

256M

Call Options Held

19M

Put Options Held

24.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $11.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.

Account

Green Alpha Advisors, LLC Moderna, Inc. Transaction History